Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Return on Equity (2021 - 2025)

Rani Therapeutics Holdings has reported Return on Equity over the past 5 years, most recently at 2.4% for Q4 2025.

  • Quarterly results put Return on Equity at 2.4% for Q4 2025, up 981.0% from a year ago — trailing twelve months through Dec 2025 was 2.4% (up 981.0% YoY), and the annual figure for FY2025 was 1.79%, up 212.0%.
  • Return on Equity for Q4 2025 was 2.4% at Rani Therapeutics Holdings, down from 5.6% in the prior quarter.
  • Over the last five years, Return on Equity for RANI hit a ceiling of 58.77% in Q1 2025 and a floor of 12.21% in Q4 2024.
  • Median Return on Equity over the past 5 years was 0.88% (2022), compared with a mean of 0.88%.
  • Biggest five-year swings in Return on Equity: tumbled -996bps in 2024 and later skyrocketed 6207bps in 2025.
  • Rani Therapeutics Holdings' Return on Equity stood at 0.42% in 2021, then tumbled by -88bps to 0.79% in 2022, then tumbled by -185bps to 2.25% in 2023, then crashed by -442bps to 12.21% in 2024, then skyrocketed by 80bps to 2.4% in 2025.
  • The last three reported values for Return on Equity were 2.4% (Q4 2025), 5.6% (Q3 2025), and 7.23% (Q2 2025) per Business Quant data.